Education: Ph.D. in Physics, University of Illinois
Years of Experience: 25+ Years
Location: Boston, MA
How do you see imaging transforming the development of novel therapies?
"Imaging is an objective surrogate biomarker that aids at different levels in the development of new therapies; from helping identify drug candidates, enriching clinical trials through patient selection, to monitoring disease progression/modification with minimally invasive methods."
What are some transformative breakthroughs that have driven precision medicine efforts?
"First and foremost, the integration across fields. Genetics, pathology and imaging have resulted in powerful approaches to precisely diagnose, prescribe and follow treatments individually."
What scientist (past or present) do you admire and why?
"Charles P. Slichter, a physicist. For his tremendous enthusiasm to understand nature, be it physics, chemistry, and/or biology and to give back."
To learn more about Invicro's services, please visit: www.invicro.com
